Fig. 3From: Survival outcomes of adjuvant taxanes, platinum plus fluoropyrimidines versus platinum and fluoropyrimidines for gastric cancer patients after D2 gastrectomy: a retrospective propensity score-matched analysisKaplan-Meier estimated overall survival curves for the gastric cancer patients with adjuvant chemotherapy before (A) and after (B) propensity score matching analysis. PF, platinum plus fluoropyrimidines; TPF, taxanes, platinum plus fluoropyrimidines; mOS, median overall survival; HR, hazard ratioBack to article page